IKK promotes naïve T cell survival by repressing RIPK1-dependent apoptosis and activating NF-κB.
Journal
Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400
Informations de publication
Date de publication:
27 06 2023
27 06 2023
Historique:
medline:
29
6
2023
pubmed:
27
6
2023
entrez:
27
6
2023
Statut:
ppublish
Résumé
The inhibitor of κB kinase (IKK) complex regulates the activation of the nuclear factor κB (NF-κB) family of transcription factors. In addition, IKK represses extrinsic cell death pathways dependent on receptor-interacting serine/threonine-protein kinase 1 (RIPK1) by directly phosphorylating this kinase. Here, we showed that peripheral naïve T cells in mice required the continued expression of IKK1 and IKK2 for their survival; however, the loss of these cells was only partially prevented when extrinsic cell death pathways were blocked by either deleting
Identifiants
pubmed: 37368952
doi: 10.1126/scisignal.abo4094
doi:
Substances chimiques
I-kappa B Kinase
EC 2.7.11.10
NF-kappa B
0
Ripk1 protein, mouse
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabo4094Subventions
Organisme : Medical Research Council
ID : MR/P011225/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013867/1
Pays : United Kingdom